MTRN Form 4: Director Prevost Reports RSUs and Deferred-Comp Acquisition
Rhea-AI Filing Summary
Patrick M. Prevost, a director of Materion Corporation (MTRN), reported acquisitions on 09/05/2025. He indirectly acquired 19.93 shares of MTRN common stock through the companys directors deferred compensation plan at a reported price of $0, increasing indirect beneficial ownership to 15,815.179 shares. Separately, he directly received 2 restricted stock units (RSUs) acquired as reinvested dividend equivalents; each RSU converts to one share and these units will vest the earlier of May 8, 2026 or the next annual shareholder meeting. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Positive
- Increased alignment with shareholders: Directors holdings rose via deferred compensation and RSU dividend reinvestment
- Transparent vesting terms disclosed: RSUs vest the earlier of May 8, 2026 or the next annual meeting
Negative
- None.
Insights
TL;DR: Routine director compensation and dividend reinvestment increased indirect holdings; no unusual departures from standard governance practice.
The Form 4 documents customary equity accruals for a director: participation in a deferred compensation plan and acquisition of dividend-equivalent RSUs. The indirect purchase of 19.93 shares at $0 reflects an internal plan mechanism rather than an open-market cash purchase, and the added 2 RSUs arise from reinvested dividends and carry standard vesting tied to the next annual meeting or a set date. There are no disclosures here of option exercises, sales, or unusual transfers that would raise governance concerns.
TL;DR: Compensation-related equity accruals increased both direct and indirect holdings; vesting schedule and dividend reinvestment are explicitly disclosed.
The report shows indirect acquisition of 19.93 common shares via the directors deferred compensation plan and direct receipt of 2 RSUs acquired as reinvested dividend equivalents. The RSUs vest the earlier of May 8, 2026 or the next annual meeting, consistent with typical retention alignment. Price reported as $0 indicates no cash paid at grant/reinvestment; this is informational and aligns with equity-based compensation mechanics rather than market purchases.